Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global…
<!-- Name:DistributionId Value:8837812 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Ambrx
Ambrx Biopharma to Host Corporate Update Conference Call
SAN DIEGO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to…